Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer

This cross-sectional study of data from the National Comprehensive Cancer Network assesses the association of prostate-specific membrane antigen positron emission tomography with tumor upstaging risk in patients with high-risk prostate cancer.

Detalles Bibliográficos
Autores principales: Brant, Aaron, Lewicki, Patrick, Xiang, Michael, Zhu, Alec, Kishan, Amar U., Pollom, Erqi Liu, Shoag, Jonathan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468886/
https://www.ncbi.nlm.nih.gov/pubmed/36094506
http://dx.doi.org/10.1001/jamanetworkopen.2022.31101
_version_ 1784788518306840576
author Brant, Aaron
Lewicki, Patrick
Xiang, Michael
Zhu, Alec
Kishan, Amar U.
Pollom, Erqi Liu
Shoag, Jonathan E.
author_facet Brant, Aaron
Lewicki, Patrick
Xiang, Michael
Zhu, Alec
Kishan, Amar U.
Pollom, Erqi Liu
Shoag, Jonathan E.
author_sort Brant, Aaron
collection PubMed
description This cross-sectional study of data from the National Comprehensive Cancer Network assesses the association of prostate-specific membrane antigen positron emission tomography with tumor upstaging risk in patients with high-risk prostate cancer.
format Online
Article
Text
id pubmed-9468886
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-94688862022-10-14 Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer Brant, Aaron Lewicki, Patrick Xiang, Michael Zhu, Alec Kishan, Amar U. Pollom, Erqi Liu Shoag, Jonathan E. JAMA Netw Open Research Letter This cross-sectional study of data from the National Comprehensive Cancer Network assesses the association of prostate-specific membrane antigen positron emission tomography with tumor upstaging risk in patients with high-risk prostate cancer. American Medical Association 2022-09-12 /pmc/articles/PMC9468886/ /pubmed/36094506 http://dx.doi.org/10.1001/jamanetworkopen.2022.31101 Text en Copyright 2022 Brant A et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Brant, Aaron
Lewicki, Patrick
Xiang, Michael
Zhu, Alec
Kishan, Amar U.
Pollom, Erqi Liu
Shoag, Jonathan E.
Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
title Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
title_full Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
title_fullStr Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
title_full_unstemmed Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
title_short Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
title_sort risk of tumor upstaging with prostate-specific membrane antigen positron emission tomography in patients with high-risk prostate cancer
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468886/
https://www.ncbi.nlm.nih.gov/pubmed/36094506
http://dx.doi.org/10.1001/jamanetworkopen.2022.31101
work_keys_str_mv AT brantaaron riskoftumorupstagingwithprostatespecificmembraneantigenpositronemissiontomographyinpatientswithhighriskprostatecancer
AT lewickipatrick riskoftumorupstagingwithprostatespecificmembraneantigenpositronemissiontomographyinpatientswithhighriskprostatecancer
AT xiangmichael riskoftumorupstagingwithprostatespecificmembraneantigenpositronemissiontomographyinpatientswithhighriskprostatecancer
AT zhualec riskoftumorupstagingwithprostatespecificmembraneantigenpositronemissiontomographyinpatientswithhighriskprostatecancer
AT kishanamaru riskoftumorupstagingwithprostatespecificmembraneantigenpositronemissiontomographyinpatientswithhighriskprostatecancer
AT pollomerqiliu riskoftumorupstagingwithprostatespecificmembraneantigenpositronemissiontomographyinpatientswithhighriskprostatecancer
AT shoagjonathane riskoftumorupstagingwithprostatespecificmembraneantigenpositronemissiontomographyinpatientswithhighriskprostatecancer

Ejemplares similares